BiotechTube
Deep 6 AI

Deep 6 AI

Pasadena, United States· Est.
deep6.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $37.7M

Overview

Deep 6 AI operates at the intersection of healthcare data and artificial intelligence, offering a software platform designed to streamline clinical trial patient recruitment. By parsing complex medical records, the company's technology can find suitable trial candidates in minutes or hours instead of the traditional months-long manual process. This capability aims to significantly reduce trial timelines and costs for pharmaceutical, biotechnology, and medical device companies. As a private company founded in 2015, Deep 6 AI targets the growing market for clinical trial optimization solutions.

AI / Machine Learning

Technology Platform

AI and NLP-powered software platform that analyzes structured and unstructured EHR and clinical data to rapidly identify patients matching complex clinical trial eligibility criteria.

Funding History

3
Total raised:$37.7M
Series B$17M
Series A$17M
Seed$3.7M

Opportunities

The growing complexity and cost of clinical trials, coupled with the push for more diverse patient populations, creates a massive demand for efficient recruitment solutions.
The expansion of real-world data and EHR adoption provides more fuel for AI-driven analysis.

Risk Factors

Heavy reliance on the quality and interoperability of hospital EHR data.
Intense competition in the clinical trial tech space and the challenge of changing entrenched industry workflows.
Evolving data privacy regulations pose a constant compliance burden.

Competitive Landscape

Deep 6 AI competes in a crowded market with other AI-enabled patient recruitment firms (e.g., TriNetX, Mendel.ai), large clinical research organizations (IQVIA, PPD), and comprehensive clinical trial software suites (Medidata, Veeva). Differentiation hinges on the sophistication of its NLP, speed of identification, and depth of EHR integration.

More companies in United States →